Association between gastric Candida colonization and surgical site infections after high-level hepatobiliary pancreatic surgeries: the results of prospective observational study - Takeaways - MDSpire

Association between gastric Candida colonization and surgical site infections after high-level hepatobiliary pancreatic surgeries: the results of prospective observational study

  • By

  • Kazuyuki Gyoten

  • Hiroyuki Kato

  • Aoi Hayasaki

  • Takehiro Fujii

  • Yusuke Iizawa

  • Yasuhiro Murata

  • Akihiro Tanemura

  • Naohisa Kuriyama

  • Masashi Kishiwada

  • Shugo Mizuno

  • Masanobu Usui

  • Hiroyuki Sakurai

  • Shuji Isaji

  • October 15, 2020

  • 0 min

Share

  • 1

    High-level hepatobiliary pancreatic surgeries have a high incidence of postoperative infectious complications despite advanced techniques.

  • 2

    Gastric Candida colonization may negatively influence the clinical course and contribute to surgical site infections after high-level surgeries.

  • 3

    The study involved 66 patients undergoing high-level HBP surgeries, focusing on the impact of gastric Candida colonization on postoperative outcomes.

  • 4

    Gastric juice was cultured to assess Candida colonization, with results classified based on growth area on specific agar plates.

  • 5

    The study protocol was ethically approved, and antifungal treatments were not administered regardless of gastric Candida colonization status.

Original Source(s)

Association between gastric Candida colonization and surgical site infections after high-level hepatobiliary pancreatic surgeries: the results of prospective observational study

  • by Kazuyuki Gyoten, Hiroyuki Kato, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Masashi Kishiwada, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Shuji Isaji

  • October 15, 2020

Related Content

Impact of an enhanced anti-infection prophylaxis strategy for pancreatoduodenectomy: a single centre analysis

Surgical site infection

Multidrug-resistant bacterial infections in the liver transplant setting